Advertisement

Related Videos

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

David A. Hyman, MD, JD, on Inclusive Shared Savings

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Advertisement

Advertisement




Nov
06
Today In Oncology
Basser Center for BRCA Announces Two Award Winners
Extended ERSPC Analysis Demonstrates Long-Term Mortality Benefit of PSA Screening for Prostate Cancer
RCC: Lenvatinib/Everolimus Extends PFS After PD-1 Inhibition
Final Overall Survival Confirms Benefit of Durvalumab Plus FLOT in Resectable Gastric and Gastroesophageal Junction Adenocarcinomas
Lung Cancer Advancements Are Saving More Lives Than Ever but Funding Cuts May Hinder Progress
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo